Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
All around the world, people are increasingly wise to the advance of AI. More than a few are growing ever more uneasy about it. And yet workers equipped with AI are both more productive and better at their jobs.
More than two-thirds of U.S. physicians have changed their minds about generative AI over the past year. In doing so, the re-thinkers have raised their level of trust in the technology to help improve healthcare.
The world’s present reckoning with a certain transformative technology ought to contain echoes of the past for CIOs and CTOs who were working their way up 10, 20 or even 30 years ago.
As part of the program, eligible Caremark members who carry commercial insurance will have GoodRX’s discounted pricing applied automatically to their prescription purchases.
Healthcare providers might be the most underrated of all AI stakeholders. Never mind that close to half of 200 CEOs surveyed believe healthcare is the field in which AI is likely to make the most transformative contribution.
Chief financial officers are the most likely members of U.S. C-suites to leave their jobs within five years of starting, whether by resignation, retirement, termination or promotion.
Nashville-based HCA Healthcare operates in 21 states, and mass numbers of patients in all but one of them may have had personal information offered for sale as a list on the deep web.
Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.